TY - JOUR
T1 - Does coexisting accommodative dysfunction impact clinical convergence measures, symptoms and treatment success for symptomatic convergence insufficiency in children?
AU - The Convergence Insufficiency Treatment Trial (CITT) Investigator Group
AU - The Convergence Insufficiency Treatment Trial – Attention, Reading Trial (CITT-ART) Investigator Group
AU - Kulp, Marjean T.
AU - Sinnott, Loraine T.
AU - Cotter, Susan A.
AU - Borsting, Eric
AU - Toole, Andrew J
AU - Chen, Angela M.
AU - Jenewein, Erin C.
AU - Morrison, Ann M.
AU - Plaumann, Maureen D
AU - Jones-Jordan, Lisa
AU - Mitchell, G. Lynn
AU - Tea, Yin C.
AU - Scheiman, Mitchell M.
AU - Cooper, Jeffrey
AU - Schulman, Erica
AU - Hamian, Kimberly
AU - Iacono, Danielle
AU - Larson, Steven
AU - Leung, Valerie
AU - Meeder, Sara
AU - Ramos, Elaine
AU - Ritter, Steven
AU - Steiner, Audra
AU - Stormann, Alexandria
AU - Vricella, Marilyn
AU - Zhu, Xiaoying
AU - Tamkins, Susanna
AU - Aguilera, Naomi
AU - Brafman, Elliot
AU - Capo, Hilda
AU - Cavuoto, Kara
AU - Crespo, Isaura
AU - Dowling, Monica
AU - Draskovic, Kristie
AU - Farag, Miriam
AU - Fischer, Vicky
AU - Grace, Sara
AU - Gutierrez, Ailen
AU - Manchola-Orozco, Carolina
AU - Martinez, Maria
AU - McKeown, Craig
AU - Osigian, Carla
AU - Pham, Tuyet Suong
AU - Small, Leslie
AU - Townsend, Natalie
AU - Gallaway, Michael
AU - Boas, Mark
AU - Calvert, Christine
AU - Franz, Tara
AU - Kratochvil, Christopher J.
N1 - Publisher Copyright:
© 2021 The Authors Ophthalmic and Physiological Optics © 2021 The College of Optometrists.
PY - 2022/1
Y1 - 2022/1
N2 - Purpose: To determine whether coexisting accommodative dysfunction in children with symptomatic convergence insufficiency (CI) impacts presenting clinical convergence measures, symptoms and treatment success for CI. Methods: Secondary data analyses of monocular accommodative amplitude (AA; push-up method), monocular accommodative facility (AF; ±2.00 D lens flippers) and symptoms (CI Symptom Survey [CISS]) in children with symptomatic CI from the Convergence Insufficiency Treatment Trial (N = 218) and CITT-Attention and Reading Trial (N = 302) were conducted. Decreased AA was defined as more than 2D below the minimum expected amplitude for age (15 – ¼ age); those with AA < 5 D were excluded. Decreased AF was defined as <6 cycles per minute. Mean near point of convergence (NPC), near positive fusional vergence (PFV) and symptoms (CISS) were compared between those with and without accommodative dysfunction using analysis of variance and independent samples t-testing. Logistic regression was used to compare the effect of baseline accommodative function on treatment success [defined using a composite of improvements in: (1) clinical convergence measures and symptoms (NPC, PFV and CISS scores) or (2) solely convergence measures (NPC and PFV)]. Results: Accommodative dysfunction was common in children with symptomatic CI (55% had decreased AA; 34% had decreased AF). NPC was significantly worse in those with decreased AA (mean difference = 6.1 cm; p < 0.001). Mean baseline CISS scores were slightly worse in children with coexisting accommodative dysfunction (decreased AA or AF) (30.2 points) than those with normal accommodation (26.9 points) (mean difference = 3.3 points; p < 0.001). Neither baseline accommodative function (p ≥ 0.12 for all) nor interaction of baseline accommodative function and treatment (p ≥ 0.50) were related to treatment success based on the two composite outcomes. Conclusions: A coexisting accommodative dysfunction in children with symptomatic CI is associated with worse NPC, but it does not impact the severity of symptoms in a clinically meaningful way. Concurrent accommodative dysfunction does not impact treatment response for CI.
AB - Purpose: To determine whether coexisting accommodative dysfunction in children with symptomatic convergence insufficiency (CI) impacts presenting clinical convergence measures, symptoms and treatment success for CI. Methods: Secondary data analyses of monocular accommodative amplitude (AA; push-up method), monocular accommodative facility (AF; ±2.00 D lens flippers) and symptoms (CI Symptom Survey [CISS]) in children with symptomatic CI from the Convergence Insufficiency Treatment Trial (N = 218) and CITT-Attention and Reading Trial (N = 302) were conducted. Decreased AA was defined as more than 2D below the minimum expected amplitude for age (15 – ¼ age); those with AA < 5 D were excluded. Decreased AF was defined as <6 cycles per minute. Mean near point of convergence (NPC), near positive fusional vergence (PFV) and symptoms (CISS) were compared between those with and without accommodative dysfunction using analysis of variance and independent samples t-testing. Logistic regression was used to compare the effect of baseline accommodative function on treatment success [defined using a composite of improvements in: (1) clinical convergence measures and symptoms (NPC, PFV and CISS scores) or (2) solely convergence measures (NPC and PFV)]. Results: Accommodative dysfunction was common in children with symptomatic CI (55% had decreased AA; 34% had decreased AF). NPC was significantly worse in those with decreased AA (mean difference = 6.1 cm; p < 0.001). Mean baseline CISS scores were slightly worse in children with coexisting accommodative dysfunction (decreased AA or AF) (30.2 points) than those with normal accommodation (26.9 points) (mean difference = 3.3 points; p < 0.001). Neither baseline accommodative function (p ≥ 0.12 for all) nor interaction of baseline accommodative function and treatment (p ≥ 0.50) were related to treatment success based on the two composite outcomes. Conclusions: A coexisting accommodative dysfunction in children with symptomatic CI is associated with worse NPC, but it does not impact the severity of symptoms in a clinically meaningful way. Concurrent accommodative dysfunction does not impact treatment response for CI.
KW - accommodative facility
KW - accommodative insufficiency
KW - children
KW - convergence insufficiency
KW - ocular accommodation
KW - symptoms
UR - http://www.scopus.com/inward/record.url?scp=85122546526&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85122546526&partnerID=8YFLogxK
U2 - 10.1111/opo.12911
DO - 10.1111/opo.12911
M3 - Article
C2 - 34730250
AN - SCOPUS:85122546526
SN - 0275-5408
VL - 42
SP - 59
EP - 70
JO - Ophthalmic and Physiological Optics
JF - Ophthalmic and Physiological Optics
IS - 1
ER -